@FierceMedDev: PolyActiva pulls in $9.5M for intraocular implant work. Story | Follow @FierceMedDev
@MarkHFierce: AutoGenomics aborted its second IPO attempt in a few years. The company promises #3, but we'll see. More | Follow @MarkHFierce
@DamianFierce: In case you missed it over the weekend, Quintiles is finally kicking off the process of going public. News | Follow @DamianFierce
> Terumo Medical is suing two rivals in U.S. District Court, accusing both of patent infringement concerning the company's TR Band radial compression device. Release
> An online industry petition supporting repeal of the new device excise tax has already attracted more than 9,000 signatures. Story
> Total hip replacements tend to fail more in women than in men, according to a new Kaiser Permanente Southern California study published in the journal JAMA Internal Medicine. Release
> The second-generation micro-bypass Glaukos iStent inject significantly decreased intraocular pressure and lowers the number of required medications, according to a new study presented at the European Society of Cataract and Refractive Surgeons. Story
> Doctors don't counsel patients well enough about the long-term risks and emotional impact of living with an implantable cardioverter defibrillator to treat irregular heart rhythms, Saint Louis University scientists have found. Release
> A former Medtronic ($MDT) executive is the new chief technology officer of Decade of Discovery, a joint partnership between the University of Minnesota and the Mayo Clinic focused on defeating diabetes. Story
> Medical devices used for infants receiving neonatal intensive care may expose them to bisphenol A, an environmental endocrine disruptor that leaches out of polycarbonate plastics, according to a new Simmons College study. Story (reg. req.)
Biotech News
@FierceBiotech: Pfizer axes CovX research unit and 100 jobs in San Diego. More | Follow @FierceBiotech
@JohnCFierce: Coronavirus, which killed 5 of the 12 people known to have been infected by it, is suited to spread easily in humans. Report | Follow @JohnCFierce
> Gilead races to FDA after hep C blockbuster hopeful scores 4th win in PhIII. Story
> Roche grabs rights to Chiasma's PhIII rare disease drug in $595M deal. Article
> Analysts assign Phytopharm to scrap heap after decisive Parkinson's failure. News
Pharma News
@FiercePharma: Novartis nixes $78M non-compete with Chairman Vasella amid frenzy of criticism from Swiss. Report | Follow @FiercePharma
@EricPFierce: Gilead recall raises question about Vistide stocks. Company tells providers to look to generic suppliers. Story | Follow @EricPFierce
@AlisonBFierce: Court: Sanofi is not liable to pay local capital gains tax for its 30B rupee acquisition of Indian vax maker Shantha. More | Follow @AlisonBFierce
> Novartis nabs another FDA-approved indication for everolimus. More
> Takeda preps for first Actos trial now opening in LA. News
Biotech Research News
> Antidepressant could reverse sickle cell disease. More
> Nicotinamide slows breast tumor growth in mice. Story
> Human stem cell trial set to begin in Japan. Item
> Compound could restore learning, memory in Angelman syndrome. Article
CRO News
> QPS swings into North Carolina with Hamner partnership. Story
> Charles River predicts strong 2013 despite Q4 slump. More
> With revenue rolling, AMRI looks to CDMO boom in 2013. Article
> Quintiles files IPO worth $600 million--or much more. News
Biotech IT News
> Genomics? There could be an app for that. Item
> Boehringer Ingelheim goes to Hungary for R&D software. More
> EU enters expensive race to map out brain secrets with computers. Article
> CLC bio capitalizes on surge in DNA sequencing. Story
Pharma Manufacturing News
> AMRI 'money pit' now money maker. Item
> GSK commits to continuous processing. More
> Gilead recalls some Vistide; supplies may be an issue. Article
> FDA lambastes Jamaican manufacturer over sterility, quality. Story